NCT02194088View on ClinicalTrials.gov

Combined Medication for Improved Analgesia in Superficial Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

June 30, 2017

Conditions
Pain
Interventions
DRUG

Diclofenac and Atropine combination drug

Diclofenac will be associated with a small dose of atropine 1.2mg

DRUG

Placebo

For each capsule of active medication, a capsule of placebo will be provided, identical looking.

Trial Locations (1)

02115

Brigham And Women's Hospital, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT02194088 - Combined Medication for Improved Analgesia in Superficial Pain | Biotech Hunter | Biotech Hunter